• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hepatocellular Carcinoma.

作者信息

Villanueva Augusto

机构信息

From the Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Graduate School of Biomedical Sciences, and the Division of Hematology and Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York.

出版信息

N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.

DOI:10.1056/NEJMra1713263
PMID:30970190
Abstract
摘要

相似文献

1
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
2
[Diagnosis and treatment of hepatocellular carcinoma].[肝细胞癌的诊断与治疗]
Dtsch Med Wochenschr. 2004 Feb 20;129(8):368-72. doi: 10.1055/s-2004-819893.
3
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma.意大利肝脏研究协会（AISF）立场文件：肝细胞癌的多学科临床方法。
Dig Liver Dis. 2013 Sep;45(9):712-23. doi: 10.1016/j.dld.2013.01.012. Epub 2013 Feb 23.
4
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.从肝癌的诊断到治疗：发达国家和发展中国家共同面临的流行问题。
World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282.
5
Managing localized unresectable hepatocellular carcinoma.局部不可切除肝细胞癌的管理
JAAPA. 2015 Jan;28(1):27-34. doi: 10.1097/01.JAA.0000458854.46279.d8.
6
Octreotide for unresectable hepatocellular carcinoma: beyond the first sight.奥曲肽用于不可切除肝细胞癌：深入探讨
J Clin Gastroenterol. 2006 Jan;40(1):86-7. doi: 10.1097/01.mcg.0000190778.50279.26.
7
Percutaneous microwave ablation of hepatocellular carcinoma with a gas-cooled system: initial clinical results with 107 tumors.采用气冷系统经皮微波消融治疗肝细胞癌：107例肿瘤的初步临床结果
J Vasc Interv Radiol. 2015 Jan;26(1):62-8. doi: 10.1016/j.jvir.2014.09.012. Epub 2014 Nov 4.
8
Modern hepatic imaging.现代肝脏影像学
Surg Clin North Am. 2004 Apr;84(2):375-400. doi: 10.1016/S0039-6109(03)00227-5.
9
Imaging diagnosis and staging of hepatocellular carcinoma.肝细胞癌的影像学诊断与分期
Liver Transpl. 2011 Oct;17 Suppl 2:S34-43. doi: 10.1002/lt.22369.
10
Radiomics in Hepatocellular Carcinoma.肝癌的放射组学。
J Gastrointest Cancer. 2020 Dec;51(4):1165-1168. doi: 10.1007/s12029-020-00493-x.

引用本文的文献

1
Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients.PNPLA3与TM6SF2基因变异在调节埃及丙型肝炎患者肝细胞癌风险中的相互作用。
Clin Exp Hepatol. 2025 Jun;11(2):169-178. doi: 10.5114/ceh.2025.151811. Epub 2025 Jun 26.
2
Screening Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Patients After Tyrosine Kinase Inhibitor Plus PD-1/PD-L1 Antibody Therapy: A Multicenter Retrospective Study.酪氨酸激酶抑制剂联合PD-1/PD-L1抗体治疗后不可切除肝细胞癌患者转化治疗候选者的筛选：一项多中心回顾性研究
J Hepatocell Carcinoma. 2025 Aug 25;12:1921-1941. doi: 10.2147/JHC.S523476. eCollection 2025.
3
Exploration of the Roles and Mechanisms Between Tumor-Infiltrating Lymphocytes and Hepatocellular Carcinoma Based on Single-Cell Transcriptomics.
基于单细胞转录组学探究肿瘤浸润淋巴细胞与肝细胞癌之间的作用及机制
Int J Genomics. 2025 Aug 20;2025:1575734. doi: 10.1155/ijog/1575734. eCollection 2025.
4
Pathological study of the tumor microenvironment after neoadjuvant therapy in hepatocellular carcinoma: Difference of TACE combined with antiangiogenics and immunotherapy.肝细胞癌新辅助治疗后肿瘤微环境的病理学研究：经动脉化疗栓塞联合抗血管生成药物与免疫治疗的差异
Hepatol Commun. 2025 Aug 29;9(9). doi: 10.1097/HC9.0000000000000787. eCollection 2025 Sep 1.
5
Prediction of Immunotherapy Response in Hepatocellular Carcinoma Patients Using Pretreatment CT Images.利用治疗前CT图像预测肝细胞癌患者的免疫治疗反应
Diagnostics (Basel). 2025 Aug 20;15(16):2090. doi: 10.3390/diagnostics15162090.
6
Prognostic Impact of Aspartate Aminotransferase-to-Platelet Ratio Index and Prognostic Nutrition Index in Hepatocellular Carcinoma Patients Undergoing Resection.天冬氨酸氨基转移酶与血小板比值指数和预后营养指数对接受手术的肝细胞癌患者的预后影响
J Clin Med. 2025 Aug 11;14(16):5665. doi: 10.3390/jcm14165665.
7
Revisiting the role of local treatments in the era of targeted therapy and immunotherapy for hepatocellular carcinoma.重新审视局部治疗在肝细胞癌靶向治疗和免疫治疗时代的作用。
World J Surg Oncol. 2025 Aug 27;23(1):323. doi: 10.1186/s12957-025-03963-3.
8
Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real-World Clinical Study.免疫疗法对不可切除的老年晚期肝细胞癌患者的影响：一项真实世界临床研究。
Cancer Med. 2025 Sep;14(17):e71171. doi: 10.1002/cam4.71171.
9
Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma.靶向FAM111B可通过增加肝细胞癌中MFN2的稳定性来减弱线粒体自噬并提高对乐伐替尼治疗的敏感性。
Cell Death Dis. 2025 Aug 25;16(1):645. doi: 10.1038/s41419-025-07941-1.
10
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.组蛋白去乙酰化酶抑制剂罗米地辛使肝癌易受受体酪氨酸激酶靶向作用影响且具有免疫活性。
Nat Commun. 2025 Aug 25;16(1):7919. doi: 10.1038/s41467-025-62934-0.